Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/1770
DC FieldValueLanguage
dc.contributor.authorLaurenti, Lucaen_US
dc.contributor.authorPetlickovski, Aleksandaren_US
dc.contributor.authorRumi, Carloen_US
dc.contributor.authorGobessi, Stefaniaen_US
dc.contributor.authorPiccioni, Paolaen_US
dc.contributor.authorTarnani, Michelaen_US
dc.contributor.authorPuggioni, Pierluigien_US
dc.contributor.authorMarietti, Saraen_US
dc.contributor.authorSica, Simonaen_US
dc.contributor.authorLeone, Giuseppeen_US
dc.contributor.authorEfremov, Dimitar Gen_US
dc.date.accessioned2019-03-21T11:41:24Z-
dc.date.available2019-03-21T11:41:24Z-
dc.date.issued2005-11-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/1770-
dc.description.abstractThe protein tyrosine kinase ZAP-70 has recently emerged as a major prognostic indicator in chronic lymphocytic leukemia (CLL). ZAP-70 is structurally and functionally homologous to Syk, a key mediator of B-cell receptor signaling. We therefore evaluated ZAP-70 expression in CLL B cells using Syk as an intracellular standard.en_US
dc.language.isoenen_US
dc.relation.ispartofHaematologicaen_US
dc.titleComparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemiaen_US
dc.typeArticleen_US
dc.identifier.volume90-
dc.identifier.issue11-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

232
checked on 19.7.2025

Google ScholarTM

Проверете


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.